A new technology that measures the levels of proteins in individual cells could help to identify therapy combinations that might more effectively treat people with multiple myeloma, a study suggests. Its researchers also report that lowering levels of a particular protein on myeloma cells, MCL-1, may make them more responsive to treatments for this cancer. The study, “Deep profiling of apoptotic pathways with mass cytometry identifies a synergistic drug combination for killing myeloma cells,” was published…
May 12, 2020May 12, 2020